File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Survival outcome after stereotactic body radiation therapy and surgery for stage i non-small cell lung cancer: A meta-analysis

TitleSurvival outcome after stereotactic body radiation therapy and surgery for stage i non-small cell lung cancer: A meta-analysis
Authors
Zheng, XiangpengSchipper, MatthewKidwell, KelleyLin, JulesReddy, RishindraRen, YanpingChang, AndrewLv, FanzhenOrringer, MarkSpring Kong, Feng Ming
Issue Date2014
Citation
International Journal of Radiation Oncology Biology Physics, 2014, v. 90, n. 3, p. 603-611 How to Cite?
DOI: http://dx.doi.org/10.1016/j.ijrobp.2014.05.055
Abstract© 2014 Elsevier Inc. Patients treated with SBRT differ substantially from patients treated with surgery in age and operability. After adjustment for these differences, OS and DFS do not differ significantly between SBRT and surgery in patients with operable stage I NSCLC. A randomized prospective trial is warranted to compare the efficacy of SBRT and surgery.
Persistent Identifierhttp://hdl.handle.net/10722/266993
ISSN
0360-3016
2023 Impact Factor: 6.4
2023 SCImago Journal Rankings: 1.992
ISI Accession Number ID
WOS:000342355400020

 

DC FieldValueLanguage
dc.contributor.authorZheng, Xiangpeng-
dc.contributor.authorSchipper, Matthew-
dc.contributor.authorKidwell, Kelley-
dc.contributor.authorLin, Jules-
dc.contributor.authorReddy, Rishindra-
dc.contributor.authorRen, Yanping-
dc.contributor.authorChang, Andrew-
dc.contributor.authorLv, Fanzhen-
dc.contributor.authorOrringer, Mark-
dc.contributor.authorSpring Kong, Feng Ming-
dc.date.accessioned2019-01-31T07:20:12Z-
dc.date.available2019-01-31T07:20:12Z-
dc.date.issued2014-
dc.identifier.citationInternational Journal of Radiation Oncology Biology Physics, 2014, v. 90, n. 3, p. 603-611-
dc.identifier.issn0360-3016-
dc.identifier.urihttp://hdl.handle.net/10722/266993-
dc.description.abstract© 2014 Elsevier Inc. Patients treated with SBRT differ substantially from patients treated with surgery in age and operability. After adjustment for these differences, OS and DFS do not differ significantly between SBRT and surgery in patients with operable stage I NSCLC. A randomized prospective trial is warranted to compare the efficacy of SBRT and surgery.-
dc.languageeng-
dc.relation.ispartofInternational Journal of Radiation Oncology Biology Physics-
dc.titleSurvival outcome after stereotactic body radiation therapy and surgery for stage i non-small cell lung cancer: A meta-analysis-
dc.typeConference_Paper-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.ijrobp.2014.05.055-
dc.identifier.pmid25052562-
dc.identifier.scopuseid_2-s2.0-84908031809-
dc.identifier.volume90-
dc.identifier.issue3-
dc.identifier.spage603-
dc.identifier.epage611-
dc.identifier.eissn1879-355X-
dc.identifier.isiWOS:000342355400020-
dc.identifier.issnl0360-3016-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats